Attention-deficit/hyperactivity disorder and substance abuse

Elizabeth Harstad; Sharon Levy; Committee on Substance Abuse

doi:10.1542/peds.2014-0992

Attention-deficit/hyperactivity disorder and substance abuse

Pediatrics. 2014 Jul;134(1):e293-301. doi: 10.1542/peds.2014-0992.

Authors

Elizabeth Harstad, Sharon Levy; Committee on Substance Abuse

Collaborators

Committee on Substance Abuse:
Sharon Levy, Seth D Ammerman, Pamela K Gonzalez, Sheryl A Ryan, Lorena M Siqueira, Vincent C Smith

PMID: 24982106
DOI: 10.1542/peds.2014-0992

Abstract

Attention-deficit/hyperactivity disorder (ADHD) and substance use disorders are inextricably intertwined. Children with ADHD are more likely than peers to develop substance use disorders. Treatment with stimulants may reduce the risk of substance use disorders, but stimulants are a class of medication with significant abuse and diversion potential. The objectives of this clinical report were to present practical strategies for reducing the risk of substance use disorders in patients with ADHD and suggestions for safe stimulant prescribing.

Keywords: ADHD; attention-deficit/hyperactivity disorder; nonstimulant medication; safe prescribing; stimulant medication; substance abuse.

Publication types

Review

MeSH terms

Attention Deficit Disorder with Hyperactivity / complications*
Attention Deficit Disorder with Hyperactivity / drug therapy*
Central Nervous System Stimulants / therapeutic use
Child
Humans
Mental Disorders / complications
Mental Disorders / drug therapy
Practice Guidelines as Topic
Substance-Related Disorders / complications*

Substances

Central Nervous System Stimulants